BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10171778)

  • 21. A preliminary comparison of major kinds of obstacles to enrolling in substance abuse treatment (AOD) reported by injecting street outreach clients and other stakeholders.
    Appel PW; Oldak R
    Am J Drug Alcohol Abuse; 2007; 33(5):699-705. PubMed ID: 17891662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Views of Australian mental health stakeholders on clients' problematic drug and alcohol use.
    Cleary M; Hunt GE; Matheson S; Walter G
    Drug Alcohol Rev; 2009 Mar; 28(2):122-8. PubMed ID: 19320696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Children with special health care needs enrolled in the State Children's Health Insurance Program (SCHIP): patient characteristics and health care needs.
    Szilagyi PG; Shenkman E; Brach C; LaClair BJ; Swigonski N; Dick A; Shone LP; Schaffer VA; Col JF; Eckert G; Klein JD; Lewit EM
    Pediatrics; 2003 Dec; 112(6 Pt 2):e508. PubMed ID: 14654673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive clinical services for substance abuse treatment in an inner-city general hospital. Substance Abuse Division, Department of Psychiatry, Bellevue Hospital, and New York University School of Medicine, New York City.
    Hosp Community Psychiatry; 1993 Oct; 44(10):991-4. PubMed ID: 8225283
    [No Abstract]   [Full Text] [Related]  

  • 25. Improving health and social care relationships for harm reduction.
    Allman D; Myers T; Schellenberg J; Strike C; Cockerill R; Cavalieri W
    Int J Drug Policy; 2007 May; 18(3):194-203. PubMed ID: 17689366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Participation in programs designed to improve employment outcomes for persons with psychiatric disabilities: evidence from the New York WORKS demonstration project.
    Ruiz-Quintanilla SA; Weathers RR; Melburg V; Campbell K; Madi N
    Soc Secur Bull; 2005-2006; 66(2):49-79. PubMed ID: 16878427
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health services research: drug use and human immunodeficiency virus in the United States.
    Flanzer J
    Clin Infect Dis; 2003 Dec; 37 Suppl 5():S439-44. PubMed ID: 14648461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
    Brannigan R; Schackman BR; Falco M; Millman RB
    Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implementing methadone medical maintenance in community-based clinics: disseminating evidence-based treatment.
    King VL; Burke C; Stoller KB; Neufeld KJ; Peirce J; Kolodner K; Kidorf M; Brooner RK
    J Subst Abuse Treat; 2008 Oct; 35(3):312-21. PubMed ID: 18294805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors related to the process of seeking and completing treatment for drug abuse (qualitative methods in drug abuse research).
    Otiashvili D; Djordjevic A; Morales D; Parsons A; Platt E; Stempliuk V
    Georgian Med News; 2005 May; (122):29-32. PubMed ID: 15988078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A community based programme to improve access to dental services for drug users.
    Charnock S; Owen S; Brookes V; Williams M
    Br Dent J; 2004 Apr; 196(7):385-8. PubMed ID: 15071524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using latent class analysis to identify patterns of hepatitis C service provision in drug-free treatment programs in the U.S.
    Strauss SM; Rindskopf DM; Astone-Twerell JM; Des Jarlais DC; Hagan H
    Drug Alcohol Depend; 2006 Jun; 83(1):15-24. PubMed ID: 16289523
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing alcohol and other drug problems (AOD) among sexually transmitted disease (STD) clinic patients with a modified CAGE-A: implications for AOD intervention services and STD prevention.
    Appel PW; Piculell R; Jansky HK; Griffy K
    Am J Drug Alcohol Abuse; 2006; 32(2):225-36. PubMed ID: 16595325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship between perceived health care quality and attitude toward substance abuse treatment].
    Rial Boubeta A; Torrado Pérez N; Braña Tobío T; Varela Mallou J
    Psicothema; 2010 Nov; 22(4):574-80. PubMed ID: 21044481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug prevention programs can work: research findings.
    Tobler NS
    J Addict Dis; 1992; 11(3):1-28. PubMed ID: 1320942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OEO drug treatment programs.
    Sparer G
    Public Health Rep; 1975; 90(5):455-9. PubMed ID: 809797
    [No Abstract]   [Full Text] [Related]  

  • 37. Statement on AIDS initiatives in drug treatment services in New York City. Committee on Public Health.
    Bull N Y Acad Med; 1991; 67(4):402-4. PubMed ID: 1651139
    [No Abstract]   [Full Text] [Related]  

  • 38. The road much less travelled: treating rural and isolated clients.
    Rainer JP
    J Clin Psychol; 2010 May; 66(5):475-8. PubMed ID: 20222117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical characteristics and service utilization patterns of clients with schizophrenia-spectrum disorders in public residential detoxification settings.
    Alvidrez J; Havassy BE
    Community Ment Health J; 2006 Apr; 42(2):131-42. PubMed ID: 16425102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accessing additional community resources through case management to meet the needs of methadone clients.
    Dennis ML; Karuntzos GT; Rachal JV
    NIDA Res Monogr; 1992; 127():54-78. PubMed ID: 1436006
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.